MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY:GS)

1,039.61 +7.03 (+0.68%)
Official Closing Price Updated: 7:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goldman Sachs Group

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
News headline image
Is Bloom Energy Impossible to Ignore Right Now? Here's What Smart Investors Should Know. ↗
Bloom Energy's share price has lost nearly a quarter of its value from the recent peak. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Capricor Therapeutics Eyes FDA Approval Path for Duchenne Cell Therapy ↗
Capricor Therapeutics (NASDAQ:CAPR) executives said the company is in active discussions with the U.S. Food and Drug Administration as it works toward a potential approval decision for deramiocel, its... 
Via MarketBeat
News headline image
BrightSpring Health Services Sees Specialty Pharmacy, Tuck-In Deals Fueling Growth ↗
BrightSpring Health Services (NASDAQ:BTSG) Chief Financial Officer Jennifer Phipps said the company’s recent growth has been driven by broad-based performance across its pharmacy and provider... 
Via MarketBeat
News headline image
SpaceX Will Have Its IPO Tomorrow: 12 Things Retail Investors Should Know ↗
SpaceX will debut on the public markets, having raised at least $75 billion at a valuation of $1.78 trillion, making it the largest initial public offering ever. 
Via The Motley Fool
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Apogee Therapeutics Maps Phase 3 Push for Zumilokibart, Backed by Blackstone Funding ↗
Apogee Therapeutics (NASDAQ:APGE) executives outlined plans to advance zumilokibart, the company’s IL-13-targeting antibody, into late-stage development for atopic dermatitis while expanding the... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape ↗
Amylyx Pharmaceuticals (NASDAQ:AMLX) Co-Chief Executive Officer Justin Klee said the company is preparing for a key Phase 3 readout for avexitide, its lead program for post-bariatric hypoglycemia,... 
Via MarketBeat
News headline image
Sweetgreen, CAVA, and Portillo's Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the CPI data showed food away from home rose only 0.3% in May, well within manageable... 
Via StockStory
Topics Economy
News headline image
Kura Sushi and Yum China Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the CPI data showed food away from home rose only 0.3% in May, well within manageable... 
Via StockStory
Topics Economy Energy
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Mission Produce, Vita Coco, and Campbell's Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The... 
Via StockStory
Topics Economy
News headline image
e.l.f. Beauty, B&G Foods, and Celsius Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The... 
Via StockStory
Topics Economy
News headline image
Utz, Edgewell Personal Care, and WD-40 Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The... 
Via StockStory
Topics Economy
News headline image
Simply Good Foods, J. M. Smucker, and Flowers Foods Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session as markets rotated into defensive names following the release of the May CPI report. The he... 
Via StockStory
Topics Economy
News headline image
Robinhood (HOOD) Stock Trades Up, Here Is Why
What Happened? Shares of financial services company Robinhood (NASDAQ:HOOD) jumped 6.4% in the afternoon session after it received regulatory approval for it... 
Via StockStory
Topics Initial Public Offering
News headline image
Alkermes Touts Orexin Ambitions as Alixorexton Enters Phase 3 and CEO Transition Nears ↗
Alkermes (NASDAQ:ALKS) executives said the company is entering a period of heightened execution as it advances its orexin agonist program into late-stage development, integrates Avadel and prepares for... 
Via MarketBeat
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
News headline image
Why Uranium Energy Stock Is Plummeting Again Today ↗
You'd be surprised to learn the real story behind the uranium stock's fall. 
Via The Motley Fool
News headline image
SpaceX Thinks Its AI Business Has $26.5 Trillion in Potential. Here's Why It May Actually Be True. ↗
Elon Musk is going all-in on artificial intelligence. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Altimmune Sets Pemvidutide’s Phase 3 MASH Playbook as AUD Data Near ↗
Altimmune (NASDAQ:ALT) management used an appearance at the Goldman Sachs Global Healthcare Conference to outline the company’s focus on pemvidutide, its lead metabolic and liver disease drug... 
Via MarketBeat
News headline image
The Grandest Castle Ever Floated (and the Stocks to Profit From It) ↗
The SpaceX IPO has Wall Street debating trillion-dollar valuations. Luke Lango argues the selloff it triggered is actually the buying opportunity investors have been waiting for in Corning, Ciena,... 
Via InvestorPlace
Topics Artificial Intelligence Initial Public Offering
News headline image
LinkedIn's New Creator Marketplace Could Reshape the Global Creator Economy
 
Via PR Leap
Topics Artificial Intelligence Economy
News headline image
Is Walmart a Millionaire-Maker Stock? ↗
What comes next for the iconic big box retailer? 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead ↗
CG Oncology (NASDAQ:CGON) Chief Executive Officer Arthur outlined the company’s upcoming clinical and regulatory milestones for cretostimogene during a presentation at the Goldman Sachs Global... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Why Signet Jewelers Stock Triumphed on Tuesday ↗
It announced a $50 million accelerated share repurchase program. 
Via The Motley Fool
News headline image
The SpaceX IPO Is Days Away. Here's How to Prepare. ↗
SpaceX is hoping to raise $75 billion at a $1.77 trillion valuation. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Goldman Sachs Just Made a Bold Statement About SpaceX. Here's Why I'm Not Buying It ↗
Things would have to go perfectly for the next half-decade. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Expro, NESR, and Nabors Industries Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after Trump said a US-Iran deal could come in "two or three days," pulling energy equities sh... 
Via StockStory
Topics Government
Tuesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗
Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics... 
Via MarketBeat
News headline image
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts ↗
Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst... 
Via MarketBeat
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story